Institute of Immunology, University of Muenster, Muenster, Germany.
Department of Cardiothoracic Surgery, University Hospital Muenster, Muenster, Germany; and.
Blood. 2019 Jul 11;134(2):134-146. doi: 10.1182/blood.2019000320. Epub 2019 May 10.
The inflammatory responsiveness of phagocytes to exogenous and endogenous stimuli is tightly regulated. This regulation plays an important role in systemic inflammatory response syndromes (SIRSs). In SIRSs, phagocytes initially develop a hyperinflammatory response, followed by a secondary state of hyporesponsiveness, a so-called "tolerance." This hyporesponsiveness can be induced by endotoxin stimulation of Toll-like receptor 4 (TLR4), resulting in an ameliorated response after subsequent restimulation. This modification of inflammatory response patterns has been described as innate immune memory. Interestingly, tolerance can also be triggered by endogenous TLR4 ligands, such as the alarmins myeloid-related protein 8 (MRP8, S100A8) and MRP14 (S100A9), under sterile conditions. However, signaling pathways that trigger hyporesponsiveness of phagocytes in clinically relevant diseases are only barely understood. Through our work, we have now identified 2 main signaling cascades that are activated during MRP-induced tolerance of phagocytes. We demonstrate that the phosphatidylinositol 3-kinase/AKT/GSK-3β pathway interferes with NF-κB-driven gene expression and that inhibition of GSK-3β mimics tolerance in vivo. Moreover, we identified interleukin-10-triggered activation of transcription factors STAT3 and BCL-3 as master regulators of MRP-induced tolerance. Accordingly, patients with dominant-negative STAT3 mutations show no tolerance development. In a clinically relevant condition of systemic sterile stress, cardiopulmonary bypass surgery, we confirmed the initial induction of MRP expression and the tolerance induction of monocytes associated with nuclear translocation of STAT3 and BCL-3 as relevant mechanisms. Our data indicate that the use of pharmacological JAK-STAT inhibitors may be promising targets for future therapeutic approaches to prevent complications associated with secondary hyporesponsiveness during SIRS.
吞噬细胞对外源和内源性刺激的炎症反应性受到严格调控。这种调控在全身炎症反应综合征(SIRS)中起着重要作用。在 SIRS 中,吞噬细胞最初会发生过度炎症反应,随后会出现继发的低反应状态,即所谓的“耐受”。这种低反应性可由 Toll 样受体 4(TLR4)的内毒素刺激诱导,导致随后的再刺激时反应减轻。这种炎症反应模式的改变被描述为固有免疫记忆。有趣的是,在无菌条件下,内源性 TLR4 配体,如警报素髓系相关蛋白 8(MRP8,S100A8)和 MRP14(S100A9),也可以触发吞噬细胞的耐受。然而,在临床上相关疾病中触发吞噬细胞低反应性的信号通路仍知之甚少。通过我们的工作,我们现在已经确定了 2 条主要的信号通路,它们在 MRP 诱导的吞噬细胞耐受中被激活。我们证明,磷脂酰肌醇 3-激酶/AKT/GSK-3β 途径干扰 NF-κB 驱动的基因表达,并且抑制 GSK-3β 可在体内模拟耐受。此外,我们发现白细胞介素 10 触发的转录因子 STAT3 和 BCL-3 的激活是 MRP 诱导的耐受的主要调节因子。因此,具有显性负 STAT3 突变的患者没有耐受发展。在心肺旁路手术这一与全身无菌应激相关的临床相关条件下,我们证实了 MRP 表达的初始诱导以及与 STAT3 和 BCL-3 的核易位相关的单核细胞的耐受诱导是相关机制。我们的数据表明,使用药理学 JAK-STAT 抑制剂可能是预防 SIRS 期间继发低反应性相关并发症的有前途的治疗方法。